According to the Irish Pharmacy Union's 2024 Pharmacy Index (Ipsos B&A, 2,000 people surveyed), 51% of Irish adults visited a pharmacy in the past week, 88% in the past month, and the average across the entire population is 15 visits per person per year. With 1,906 community pharmacies operating across the country, this is one of the most visit-dense retail categories in Ireland.
And yet most Irish pharmacy visits leave no data trace: no name recorded, no email captured, no way to reach that customer before the next prescription falls due. The loyalty that already exists in pharmacy is invisible to the business because there is no structure around it.
That is the pharmacy loyalty gap, and this article explains how to close it.
The commercial starting position in pharmacy is stronger than most brands realise. The 2024 Pharmacy Index also found that 42% of Irish adults live within 1km of their nearest pharmacy. According to a PwC/IPU report on Irish pharmacy patient behaviour, 51% of patients "always use" the same pharmacy, and 83% always or predominantly use the same one.
This is already loyal behaviour. The customer is already choosing your pharmacy over alternatives, repeatedly, by habit. A structured loyalty program does not create this loyalty: it captures it, measures it, and makes it commercially useful. That data then opens the door to personalised promotions, seasonal health triggers, and consultation room bookings that drive incremental revenue without relying on acquisition.
Pharmacy loyalty is not about changing behaviour from scratch. It is about recognising what is already happening and building a structure around it, which puts pharmacy in a better starting position than almost any other sector entering loyalty for the first time.
Running a points program for a pharmacy is not the same as running one for a coffee shop or supermarket. The product mix includes items that carry personal health implications, and the purchase data can be sensitive in ways most retail operators never encounter.
In October 2024, the European Court of Justice issued its ruling in Case C-21/23, the Lindenapotheke case. The court held that purchase data for non-prescription OTC medicines constitutes health data under GDPR Article 9 where it allows conclusions about a customer's health status. The court applied a "probabilities test": absolute certainty is not required. If there is a meaningful degree of probability that purchase data reveals something about health status, it qualifies as special category data requiring explicit consent under Article 9(2)(a). Even a customer's name, delivery address, and the OTC product they bought can cross this threshold.
In Ireland, the Data Protection Commission is the supervisory authority for GDPR. This ruling means any loyalty scheme that collects and uses OTC purchase history must have explicit consent in place. It also means the data model for a pharmacy loyalty program must be designed with this in mind from the very start, not retrofitted for compliance after launch.
The second difference is the professional relationship. Pharmacists provide healthcare advice that patients trust. A loyalty mechanic that appears to monetise that advice, or that uses health purchase data without clear consent, risks undermining the relationship that makes the pharmacy valuable. Thoughtful design is a commercial requirement, not only a compliance one.
Within these constraints, there is a practical toolkit that works well. The most common mechanic is OTC points, where customers earn points on eligible non-prescription purchases and redeem them for discounts on future visits. Both major Irish pharmacy chains use this approach, which brings us to what the market leaders are actually doing.
Beyond points, health milestone rewards, tying a reward to completing a flu vaccination booking, attending a blood pressure check, or visiting a consultation room, add genuine health value to the programme and drive appointment frequency. With 440,000 consultation room visits recorded per month across Irish pharmacies, up 7% year on year per the 2024 Pharmacy Index, this mechanic has a clear foundation to build on.
Seasonal promotions, timed to health moments like January wellness, flu season, and hay fever season, drive OTC basket size during periods when customers are already motivated to spend. These do not require a full loyalty platform to execute and can sit on top of a simpler card or stamp model.
Prescription collection reminders are a high-value retention tool, handled carefully. A reminder that a prescription is ready to collect is a service communication. Using prescription data to generate a product recommendation without appropriate consent is a GDPR risk. This separation must be built into the system design from the start.
The design principles for a GDPR-compliant pharmacy loyalty scheme are straightforward once the Lindenapotheke ruling is understood.
Exclude prescription and licensed medicines from the points model entirely. This is what both Boots and McCabes do, and it removes the most sensitive layer of health data from the loyalty dataset. Treat OTC purchase history as special category data by default. Do not assume a product is low-risk because it is available without prescription. Apply the probabilities test: could this purchase, linked to a name, reveal something about health status? If yes, explicit consent is required before the data is used for marketing personalisation.
Obtain layered consent at registration. Customers should be able to join the points programme without automatically consenting to OTC purchase history use for targeting. Personalised health offers require a separate explicit consent layer. Conduct a Data Protection Impact Assessment before launch, and keep loyalty data and clinical records in entirely separate systems from day one.
Boots Ireland operates 95 stores in the Republic and generated revenue of more than €580 million in the 12 months to August 2024. Its Advantage Card awards 3 points per euro spent on eligible products, with each point worth 1 cent. The Over 60s Rewards Club earns 8 points per euro on Boots brand products, a strong incentive for a high-frequency demographic. The Boots app has been updated into a full loyalty hub with targeted offers.
McCabes Pharmacy, which completed its rebrand from LloydsPharmacy Ireland starting August 29, 2024, is now Ireland's largest community pharmacy chain with 110 locations. Its McCabes PLUS loyalty app awards 1 point per euro on eligible products (prescriptions excluded), and combines prescription ordering, appointment booking, and a loyalty wallet in a single experience.
For independent pharmacy groups, the differentiator is not the technology. It is the relationship. Where Boots and McCabes compete on scale, an independent pharmacy competes on personal service and community presence. A loyalty programme built around the pharmacist relationship, recognising regulars by name and rewarding consistent visits, can build engagement that a national chain cannot replicate. You can explore how Brandfire has delivered this kind of programme across multiple sectors at brandfire.ie/work/.
App-based programmes offer push notifications, prescription reminders, and rich data capture. But Irish pharmacy skews toward older adults who are the highest-frequency visitors, and physical cards have a significantly lower barrier to entry for this demographic. The practical answer for most pharmacy groups entering loyalty for the first time is to start with a card and build toward app functionality over time.
A card programme launches in weeks, requires less integration, and builds a member database before any app spend is committed. Once the database exists, email and SMS deliver much of the personalisation benefit without requiring app adoption. Starting with a card ensures no customer segment is excluded on day one.
Three metrics matter most. Visit frequency per active member, benchmarked against the national IPU average of 15 visits per person per year, shows whether the programme is changing behaviour. OTC spend per visit for members versus non-members shows whether basket size is growing. The Irish OTC market was worth €571 million in the 12 months to April 2024, according to IQVIA data cited by Irish Pharmacy News, with pain relief alone at €157 million. Even a modest basket uplift per visit across a loyal member base adds up quickly.
Prescription retention rate measures whether loyalty members are less likely to transfer their prescription to a competitor. Given the 83% same-pharmacy stickiness already in the Irish market, a programme that strengthens this behaviour protects significant long-term revenue.
Set baselines before launch. Measure monthly for the first twelve months. Early sign-up data is not representative of steady-state performance.
An independent pharmacy group can move from nothing to a live loyalty programme in eight weeks with a defined scope.
Weeks 1-2 cover scoping and compliance: defining earn categories, conducting a DPIA, drafting privacy notices, and selecting a platform. Weeks 3-4 cover POS integration and sign-up flow build including layered consent capture. Week 5 covers staff training, the most underinvested step in most pharmacy loyalty launches. Staff who understand the programme drive enrolment at a far higher rate than any in-store poster. Weeks 6-7 run a soft launch in one or two locations. Week 8 is full rollout, informed by soft launch data.
If POS integration is complex or a new app is involved, add two to four weeks to the platform phase.
Irish pharmacy is one of the few sectors where loyalty already exists at scale before a programme is launched. The IPU data confirms it: 88% of Irish adults in a pharmacy last month, 83% predominantly using the same one, 2.1 million visits per week. The commercial case does not need to be argued from first principles. It needs a programme designed to capture what is already happening.
At Brandfire, we design loyalty programs for Irish brands across health, financial services, and consumer goods. If you want to explore what a pharmacy loyalty programme could look like for your business, get in touch with our team and we can start with the numbers that matter for your specific context.
Can an independent pharmacy afford a loyalty program?
Yes. Cloud-based platforms have brought entry costs down. A single-location pharmacy can launch a digital stamp card or points wallet without a large upfront investment. Start simple, measure OTC basket uplift from week one, and reinvest before adding features.
Are prescription medicines excluded from pharmacy loyalty schemes in Ireland?
In practice, yes. Boots Ireland and McCabes Pharmacy both exclude prescription-only and licensed medicines from points earning. Prescription data is clearly health data under GDPR Article 9. Excluding prescriptions keeps the data model clean and the legal exposure manageable.
What is the Lindenapotheke ruling and why does it matter?
In October 2024, the ECJ ruled in Case C-21/23 that OTC medicine purchase data is health data under GDPR Article 9 where it allows conclusions about health status. Irish pharmacies must have explicit consent in place for any OTC purchase history they hold and use.
How long does it take to launch a pharmacy loyalty program?
Around eight weeks for an independent group with defined scope, assuming a card-based or platform-based approach. POS integration complexity and app development add time. Working with a specialist agency using pre-built infrastructure keeps the timeline short.
What metrics should a pharmacy track to measure loyalty ROI?
Visit frequency per member (benchmark against the IPU national average of 15 visits per person per year), OTC spend per visit for members versus non-members, and prescription retention rate. Secondary metrics include app open rate and consultation room booking rate.
Is a loyalty card or app better for Irish pharmacy customers?
Both have a place. Cards suit older, lower-digital customers. Apps suit prescription ordering, personalised offers, and push reminders. A hybrid model, where a card links to an app profile, captures the widest audience. McCabes PLUS uses this approach across its 110-pharmacy network.